Corganicum

Corganicum provides small-molecule active pharmaceutical ingredient (API) and chemistry consulting services for chemical, biotechnology, pharmaceutical, and start-up companies. It supports organizations and individuals working to develop and commercialize new molecules, including university affiliates, inventors, and medicinal, process, biological, and analytical chemists. Its services focus on synthetic organic chemistry, manufacturing, troubleshooting, and feasibility studies that can help clients build in-house data and confidence ahead of funding or project milestones.

Corganicum offers flexible ways to engage, from on-demand expert opinions and fee-for-service work to arrangements involving downpayments, milestone-based payments, or company shares. The company says its flexible compensation options are designed to accommodate different budgets and project stages, helping clients prepare for progress even before funding is secured. It can also connect clients with contract development and manufacturing organizations (CDMOs), contract research organizations (CROs), universities, research institutes, raw-material manufacturers, indirect suppliers, and funding consultants. Corganicum welcomes connections with individuals, small and medium-sized enterprises, companies, manufacturers, and service providers.